Acular LS vs. Nevanac in Post op Inflammation Following Cataract Surgery

Overview

The purpose of this study is to compare the clinical outcomes, safety and efficacy in patients randomized to receive either ketorolac or nepafanac following cataract surgery.

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Masking: Single

Interventions

  • Drug: Ketorolac, Nepafenac

Participating in This Clinical Trial

Inclusion Criteria

  • · Male or female > 18 years of age scheduled to undergo cataract surgery – Must be in good general health. Patients with systemic diseases will be enrolled only if there are no ocular manifestations of their disease (ie diabetics with normal retinal exams) – Ability to provide informed consent and likely to complete all study visits Exclusion Criteria:

  • · Known contraindication to any study medication or any of their components – Uncontrolled systemic disease – Required use of ocular medications other than the study medications during the study – Abnormal pre-operative OCTs if obtainable – Diabetic patients – Use of oral NSAIDS – Patients with ocular disease (macula degeneration, glaucoma, corneal disease) which reduces the potential visual rehabilitation (patients will ocular disease that will no preclude achievement of a 20/20 visual outcome may be included)..

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Investigator Details

  • Lead Sponsor
    • Innovative Medical
  • Overall Official(s)
    • Francis Mah, MD, Principal Investigator, University Pittsburgh Medical Center Eye and Ear Institute

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.